Hostname: page-component-7bb8b95d7b-cx56b Total loading time: 0 Render date: 2024-10-03T01:08:00.508Z Has data issue: false hasContentIssue false

Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates

Published online by Cambridge University Press:  22 August 2023

Deborah S. Yokoe*
Affiliation:
University of California San Francisco School of Medicine, UCSF Health-UCSF Medical Center, San Francisco, California, United States
Sonali D. Advani
Affiliation:
Duke University School of Medicine, Durham, North Carolina, United States
Deverick J. Anderson
Affiliation:
Duke University School of Medicine, Durham, North Carolina, United States
Hilary M. Babcock
Affiliation:
BJC Healthcare, Washington University School of Medicine, St. Louis, Missouri, United States
Michael Bell
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Sean M. Berenholtz
Affiliation:
Johns Hopkins University, Baltimore, Maryland, United States
Kristina A. Bryant
Affiliation:
Norton Healthcare, University of Louisville School of Medicine, Louisville, Kentucky, United States
Niccolò Buetti
Affiliation:
Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Center, Geneva, Switzerland IAME-U1137, Université Paris-Cité, INSERM, Paris, France
Michael S. Calderwood
Affiliation:
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
David P. Calfee
Affiliation:
Weill Cornell Medicine, New York, New York, United States
Erik R. Dubberke
Affiliation:
Washington University School of Medicine, St. Louis, Missouri, United States
Katherine D. Ellingson
Affiliation:
College of Public Health, The University of Arizona, Tucson, Arizona, United States
Neil O. Fishman
Affiliation:
Penn Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Dale N. Gerding
Affiliation:
Edward Hines Jr. Veterans’ Affairs Hospital, Hines, Illinois, United States
Janet Glowicz
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Mary K. Hayden
Affiliation:
Rush University Medical Center, Chicago, Illinois, United States
Keith S. Kaye
Affiliation:
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Michael Klompas
Affiliation:
Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, United States
Larry K. Kociolek
Affiliation:
Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, United States
Emily Landon
Affiliation:
The University of Chicago Medical Center, MacLean Center for Clinical Medical Ethics, Chicago, Illinois, United States
Elaine L. Larson
Affiliation:
Columbia School of Nursing, New York, New York, United States
Anurag N. Malani
Affiliation:
Trinity Health Michigan, Ann Arbor, Michigan, United States
Jonas Marschall
Affiliation:
Washington University School of Medicine, St. Louis, Missouri, United States Bern University Hospital, University of Bern, Bern, Switzerland
Jennifer Meddings
Affiliation:
University of Michigan Medical School, Ann Arbor, Michigan, United States Veterans’ Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, United States
Leonard A. Mermel
Affiliation:
Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States Lifespan Hospital System, Providence, Rhode Island, United States
Payal K. Patel
Affiliation:
Intermountain Healthcare, Salt Lake City, Utah, United States
Trish M. Perl
Affiliation:
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Kyle J. Popovich
Affiliation:
Rush University Medical Center, Chicago, Illinois, United States
Joshua K. Schaffzin
Affiliation:
Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada
Edward Septimus
Affiliation:
Texas A&M College of Medicine, Houston, Texas, United States Harvard Pilgrim Healthcare, Boston, Massachusetts, United States
Kavita K. Trivedi
Affiliation:
Alameda County Public Health Department, San Leandro, California, United States
Robert A. Weinstein
Affiliation:
Rush University Medical Center, Chicago, Illinois, United States Cook County Health, Chicago, Illinois, United States
Lisa L. Maragakis
Affiliation:
Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland, United States
*
Corresponding author: Deborah S. Yokoe; Email: deborah.yokoe@ucsf.edu
Rights & Permissions [Opens in a new window]

Abstract

Type
SHEA/IDSA/APIC Practice Recommendations
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© Society for Healthcare Epidemiology of America, 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Introduction to the Executive Summary

This document summarizes the recommendations that are included within each section of “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates.” Reference Buetti, Marschall and Drees1Reference Patel, Advani and Kofman8

Appendix Tables 1 and 2 describe the criteria used to determine the quality of evidence ratings and classification of recommendations as essential practices versus additional approaches. These criteria are discussed in more detail in the “Introduction to a Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates,” Reference Yokoe, Maragakis and Advani9 which also provides a summary of the background and the methods used to develop the Compendium: 2022 Updates. The individual Compendium 2022 sections Reference Buetti, Marschall and Drees1Reference Patel, Advani and Kofman8 summarize the major changes to the recommendations from the Compendium: 2014 Updates. Reference Yokoe, Anderson and Berenholtz10

Appendix Table 3 lists the authors and members of the Advisory Group and Expert Panel for the Compendium: 2022 Updates.

Executive summary

Strategies to prevent catheter-associated urinary tract infections (CAUTIs)

Strategies to prevent central-line–associated bloodstream infections (CLABSIs)

Strategies to prevent Clostridioides difficile infections (CDIs)

Strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission and infection

Strategies to prevent surgical-site infections (SSIs)

Strategies to prevent ventilator-associated pneumonia (VAP) and ventilator-associated events (VAEs)

Adult patients

Preterm neonatal patients

Pediatric patients

Strategies to prevent nonventilator hospital-acquired pneumonia (NV-HAP)

Strategies to prevent healthcare-associated infections through hand hygiene

Implementing strategies to prevent healthcare-associated infections

Standard approach to implementation

Examples of implementation frameworks

Acknowledgments

The Compendium Partners thank the authors for their dedication to this work, including maintaining adherence to the rigorous process for the development of the Compendium: 2022 Updates, involving but not limited to screening of thousands of articles; achieving multilevel consensus; and consideration of, response to, and incorporation of many organizations’ feedback and comments. We acknowledge these efforts especially because they occurred as the authors handled the demands of the COVID-19 pandemic. The authors thank Valerie Deloney, MBA, for her organizational expertise in the development of this manuscript and Janet Waters, MLS, BSN, RN, for her expertise in developing the strategies used for the literature searches that informed this manuscript. The authors thank the many individuals and organizations who gave their time and expertise to review and provide comments on the Compendium: 2022 Updates, including 2018–2023 members of the SHEA Guidelines Committee, the SHEA Publications Committee, which helped oversee the planning and development of the Compendium: 2022 Updates, and the SHEA Board of Trustees; the IDSA Standards and Practice Guidelines Committee and the IDSA Board of Directors; members of the National Foundation of Infectious Diseases (NFID) Sara E. Cosgrove, MD, MS (MRSA, CAUTI, SSI, CDI), Kathleen H. Harriman, PhD, MPH, RN (MRSA), S. Shaefer Spires, MD (MRSA, CAUTI, SSI, CDI); members of the Society of Infectious Diseases Pharmacists (SIDP) Emily Heil, MD (VAP/VAE/NV-HAP), Kayla R. Stover Hielscher, PharmD (VAP/VAE/NV-HAP), David A. Cretella, PharmD (VAP/VAE/NV-HAP), Tracy Zembles, PharmD (Implementation), Mary Joyce B. Wingler, PharmD (Implementation), Jarrett Amsden, PharmD (Implementation), and Alan E. Gross, PharmD; and members of the Surgical Infection Society (SIS) Joseph Cuschieri, MD, Rondi B. Gelbard, MD, Sabrina D. Goddard, MD, George E. Koch, MD, and Sebastian D. Schubl, MD. The Compendium Partners and authors thank everyone who contributed and whose input informed and improved the Compendium: 2022 Updates. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the US Department of Veterans’ Affairs.

Financial support

Financial support for the Compendium: 2022 Updates was provided by the Society for Healthcare Epidemiology of America (SHEA).

Conflict of interest disclosure

The following disclosures reflect what has been reported to SHEA. To provide thorough transparency, SHEA requires full disclosure of all relationships, regardless of relevancy to the topic. Such relationships as potential conflicts of interest are evaluated in a review process that includes assessment by the SHEA Conflict of Interest Committee and may include the Board of Trustees and Editor of Infection Control and Hospital Epidemiology. The assessment of disclosed relationships for possible conflicts of interest has been based on the relative weight of the financial relationship (ie, monetary amount) and the relevance of the relationship (ie, the degree to which an association might reasonably be interpreted by an independent observer as related to the topic or recommendation of consideration). Potential conflicts have been disclosed by the Compendium: 2022 Updates authors as follows:

CAUTI section: S.A. reports consulting fees with IDSA, bioMerieux, Locus Biosciences, and GSK, and participation on a bioMerieux Advisory Board, and is co-owner of IPEC Experts, LLC. J.M. reports grant funding from the AHRQ, the CDC, the Ralph E. Wilson Foundation, and the VA HSR&D. All other authors report no conflicts of interest related to this article.

CDI section: L.K.K. reported a research grant from Merck. R.C. reported an advisory role with Moderna, Novavax, and Pfizer (consultant, speakers bureau, research contract), and Sanofi (speakers bureau). C.J.D. reported a research grants from Clorox and Ecolab. G.D. reported a research grant from Pfizer. V.G.L. reported a consultant role with Ferring. D.J.W. reported advisory roles for Merck, Pfizer, PDI, Wellair, GAMA, and Germitec, and serving as a data safety monitoring board member at GSK. E.R.D. reported advisory roles for Merck, Pfizer, Seres, Ferring, Abbott, Summit, GSK, and research grants from Pfizer, Theriva Biologics, and Ferring. All other authors report no conflicts of interest related to this article.

CLABSI section: N.B. received Mobility grants from the Swiss National Science Foundation (grant nos. P400PM_183865 and P4P4PM_194449) and a grant from the Bangerter-Rhyner Foundation. J.M. is the recipient of a project grant on surgical-site infections from the Swiss National Science Foundation (grant no. 32003B_179500, “Understanding the drivers of surgical site infection: Investigating and modeling the Swissnoso surveillance data”). L.M. served as an advisor and consultant to Marvao Medical Devices, Pristine Access Technologies, and Citius Pharma. L.H. served as an advisor and consultant to B Braun Medical, BD Medical, Atrion Medical, Nexus Medical, Teleflex. M.E.R. served as an advisor and consultant to 3M, Becton Dickinson, and Cetius, and Teleflex, and received honoraria from Teleflex. All other authors report no conflicts of interest related to this article.

Hand hygiene section: A.A. reported payment from the analysis group for an expert presentation on litigation for prevention of infection in the community setting. K.H. reported consulting for Medillum and Nozin, a grant from the NC Department of Public Health, and providing a lecture for PDI. R.O. reported consulting for Specified Technologies and Northshore University Health System, providing expert testimony for Saxton & Stump, providing a lecture for the Teleflex Medical Advisory Board, providing subject-matter expertise for APIC for AHA HRET, and performing peer review of a manuscript for Joint Commission Resources. All other authors report no conflicts of interest related to this article.

MRSA section: A.M. received a research grant from Merck. A.H. served as an advisory and consultant for Cubist, UpToDate, and Premier, Inc. S.H. led a clinical trial in which participating hospitals received contributed product from Sage Products, Inc. J.M. conducted a clinical trial in which participating hospitals received contributed product from Sage Products, Inc. All other authors report no conflicts of interest related to this article.

SSI section: D.J.A. is the owner of Infection Control Education for Major Sports, LLC, has grants from the CDC and the AHRQ and has received royalties for authorship on UpToDate. A.C.N. is the Data and Safety Monitoring Board Chair for the CAV-AVI Neonatal PK Study with Pfizer. All other authors report no conflicts of interest related to this article.

VAP, VAE, NV-HAP section: M.K. has received grant funding from CDC and AHRQ plus royalties from UpToDate, Inc. R.B. has served as an advisor and consultant to Pfizer, Mallinckrodt, Ventec Life Systems, Vyaire and Zoll Medical. K.A.C. has received honoraria from BD, CloroxPro, and Elsevier. L.R.G. has received honoraria from Premier, Inc, Care Fusion, Infection Control Today, and Advanced Sterilization Products. All other authors report no conflicts of interest related to this article.

Implementation section: K.K.T. is the owner of the consulting company Trivedi Consults, LLC. V.M.D. is the owner of the consulting company Youngtree Communications, LLC. R.C. has consulting relationships with Moderna, Novavax, and Pfizer (speakers bureau, research contract) and Sanofi (speakers bureau). M.L.S. has grant funding from 3M and PDI for nasal decolonization. All other authors report no conflicts of interest related to this article.

Expert Panel: H.M.B. reports institutional funding from CDC for a Prevention Epicenter; K.A.B. is the PI for multicenter clinical trials funded for institution by Pfizer, Gilead, and Enanta; M.K.H. reports institutional funding from CDC for a Prevention Epicenter and from the Chicago Department of Public Health for a Regional Innovative Public Health Laboratory; R.A.W. is a paid reviewer for UpToDate. All other authors report no conflicts of interest related to this article.

Appendix

Table 1. Quality of Evidence

Based on the CDC Healthcare Infection Control Practices Advisory Committee (HICPAC) “Update to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee Recommendations Categorization Scheme for Infection Control and Prevention Guideline Recommendations” (October 2019), 34 the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE), Reference Guyatt, Oxman and Vist35 and the Canadian Task Force on Preventive Health Care. 36

Table 2. Level of Recommendation

Table 3. Compendium Leadership and Authors

Footnotes

*

These authors are contributed equally.

References

Buetti, N, Marschall, J, Drees, M, et al. Strategies to prevent central-line–associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2022;43:553569.CrossRefGoogle Scholar
Klompas, M, Branson, R, Cawcutt, K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2022;43:687713.CrossRefGoogle ScholarPubMed
Glowicz, J, Landon, E, Sickbert Bennett, EE, et al. Compendium of strategies to prevent healthcare-associated infections through hand hygiene: 2022 update. Infect Control Hosp Epidemiol 2023;44:355376.CrossRefGoogle Scholar
Kociolek, LK, Gerding, DN, Carrico, R, et al. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023;44:527549.10.1017/ice.2023.18CrossRefGoogle Scholar
Calderwood, MS, Anderson, DJ, Bratzler, DW, et al. Strategies to prevent surgical-site infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023;44:695720.CrossRefGoogle ScholarPubMed
Popovich, KJ, Aureden, K, Ham, DC, et al. SHEA/IDSA/APIC practice recommendation: strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023:129.CrossRefGoogle Scholar
Trivedi, KK, Schaffzin, J, Deloney, V, et al. Implementing strategies to prevent infections in acute-care settings. Infect Control Hosp Epidemiol 2023:1–15.Google Scholar
Patel, P, Advani, S, Kofman, A, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023. doi: 10.1017/ice.2023.158 CrossRefGoogle Scholar
Yokoe, D, Maragakis, L, Advani, S, et al. Introduction to a compendium of strategies to prevent healthcare-associated infections in acute-care hospitals: 2022 updates. Infect Control Hosp Epidemiol 2023. doi: 10.1017/ice.2023.137 CrossRefGoogle Scholar
Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. Introduction to “A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates”. Infect Control Hosp Epidemiol 2014;35(Suppl 2):S1S5.CrossRefGoogle ScholarPubMed
Pronovost, PJ, Berenholtz, SM, Needham, DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ 2008;337:a1714.10.1136/bmj.a1714CrossRefGoogle Scholar
Berenholtz, SM, Lubomski, LH, Weeks, K, et al. Eliminating central-line–associated bloodstream infections: a national patient safety imperative. Infect Control Hosp Epidemiol 2014;35:5662.CrossRefGoogle ScholarPubMed
Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:27252732.10.1056/NEJMoa061115CrossRefGoogle Scholar
Pronovost, PJ, Watson, SR, Goeschel, CA, Hyzy, RC, Berenholtz, SM. Sustaining reductions in central-line–associated bloodstream infections in Michigan intensive care units: a 10-year analysis. Am J Med Qual 2016;31:197202.CrossRefGoogle ScholarPubMed
Lipitz-Snyderman, A, Steinwachs, D, Needham, DM, Colantuoni, E, Morlock, LL, Pronovost, PJ. Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis. BMJ 2011;342:d219.CrossRefGoogle ScholarPubMed
Waters, HR, Korn, R Jr, Colantuoni, E, et al. The business case for quality: economic analysis of the Michigan Keystone Patient Safety Program in ICUs. Am J Med Qual 2011;26:333339.CrossRefGoogle ScholarPubMed
Rawson, TM, Moore, LS, Tivey, AM, et al. Behaviour change interventions to influence antimicrobial prescribing: a cross-sectional analysis of reports from UK state-of-the-art scientific conferences. Antimicrob Resist Infect Control 2017;6:11.CrossRefGoogle ScholarPubMed
Michie, S, Atkins, L, West, R. The Behavior Change Wheel: A Guide to Designing Interventions. Sutton, England: Silverback Publishing; 2014.Google Scholar
Munir, F, Biddle, SJH, Davies, MJ, et al. Stand More AT Work (SMArT Work): using the behaviour change wheel to develop an intervention to reduce sitting time in the workplace. BMC Public Health 2018;18:319.CrossRefGoogle ScholarPubMed
How to Use the CUSP Toolkit. Agency for Healthcare Research and Quality website. https://www.ahrq.gov/hai/cusp/toolkit/index.html. Updated July 2018. Accessed July 12, 2023.Google Scholar
Eliminating catheter-associated urinary tract infections. American Hospital Association website. http://www.hpoe.org/resources/ahahret-guides/1420. Accessed July 12, 2023.Google Scholar
Toolkit to Improve Safety in Ambulatory Surgery Centers. Agency for Healthcare Research and Quality website. https://www.ahrq.gov/hai/tools/ambulatory-surgery/index.html. Updated 2023. Accessed July 12, 2023.Google Scholar
van der Kooi, TII, Smid, EA, Koek, MBG, et al. The effect of an intervention bundle to prevent central venous catheter–related bloodstream infection in a national programme in the Netherlands. J Hosp Infect 2023;131:194202.CrossRefGoogle Scholar
Ebener, P, Hunter, S, Adams, R, Eisenman, D, Acosta, J, Chinman, M. Getting to outcomes guide for community emergency preparedness. RAND Corporation website. https://www.rand.org/pubs/tools/TL259.html. Published 2017. Accessed July 12, 2023.CrossRefGoogle Scholar
Resources. Institute for Healthcare Improvement website. https://www.ihi.org/resources/Pages/default.aspx. Accessed July 12, 2023.Google Scholar
Langley, G, Moen, R, Nolan, KM, Nolan, T, Norman, C, Provost, L. The improvement guide: a practical approach to enhancing organizational performance. Agency for Healthcare Research and Quality website. https://psnet.ahrq.gov/issue/improvement-guide-practical-approach-enhancing-organizational-performance-2nd-ed. Accessed July 12, 2023.Google Scholar
The Deming System of Profound Knowledge (SoPK). The W. Edwards Deming Institute website. https://deming.org/explore/sopk/ Google Scholar
RE-AIM. RE-AIM and PRISM: implementation in context. https://re-aim.org/ Google Scholar
Holtrop, JS, Estabrooks, PA, Gaglio, B, et al. Understanding and applying the RE-AIM framework: clarifications and resources. J Clin Transl Sci 2021;5:e126.10.1017/cts.2021.789CrossRefGoogle Scholar
HIV/AIDS Prevention Research Synthesis Project. Compendium of HIV prevention interventions with evidence of effectiveness. Centers for Disease Control and Prevention website. https://www.cdc.gov/hiv/pdf/research/interventionresearch/rep/prevention_research_compendium.pdf. Published November 1999. Revised August 2001. Accessed July 2023.Google Scholar
Atkins, L, Francis, J, Islam, R, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci 2017;12:77.CrossRefGoogle ScholarPubMed
French, SD, Green, SE, O’Connor, DA, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implement Sci 2012;7:38.CrossRefGoogle Scholar
Grimshaw, JM, Patey, AM, Kirkham, KR, et al. De-implementing wisely: developing the evidence base to reduce low-value care. BMJ Qual Saf 2020;29:409417.CrossRefGoogle ScholarPubMed
Update to the CDC and the HICPAC Recommendation Categorization Scheme for Infection Control and Prevention Guideline Recommendations. Centers for Disease Control and Prevention website. https://www.cdc.gov/hicpac/workgroup/recommendation-scheme-update.html. Accessed July 12, 2023.Google Scholar
Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924926.CrossRefGoogle ScholarPubMed
Grades of Recommendation, Assessment, Development, and Evaluation (GRADE). Canadian Task Force on Preventive Health Care website. https://canadiantaskforce.ca/wp-content/uploads/2018/12/GRADE-Info-for-website-blue-format-181220.pdf. Accessed July 12, 2023.Google Scholar
Figure 0

Table 1. Quality of Evidence

Figure 1

Table 2. Level of Recommendation

Figure 2

Table 3. Compendium Leadership and Authors